Modulation of THC Effects by CBD: a Dose-ranging Study

NCT06099379 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cannabis
THC

Interventions

DRUG: ∆9-tetrahydrocannabinol

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)